EFFECT OF DENOSUMAB ON CLINICAL AND RADIOLOGICAL CHANGES IN RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS
Current therapy for rheumatoid arthritis (RA) should not only suppress inflammation, but should also prevent local and generalized bone mineral density (BMD) loss. The drug of choice to treat secondary osteoporosis (OP) is denosumab, a monoclonal antibody, which binds RANKL, inhibiting the inte...
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | Russian |
| Baskı/Yayın Bilgisi: |
IMA PRESS LLC
2015-04-01
|
| Seri Bilgileri: | Научно-практическая ревматология |
| Konular: | |
| Online Erişim: | https://rsp.mediar-press.net/rsp/article/view/2066 |